Market Research

Canine Atopic Dermatitis Market (Product Type: Glucocorticoids, Immunosuppressants, Monoclonal Antibodies, Calcineurin inhibitors, Janus kinase (JAK) inhibitor and Others; and Route of Administration: Topical, Oral and Injectable) - Global Industry Analys

Best Price Guarantee Length Publisher Published Date SKU
from $5,795 242 Pages Transparency Market Research Pvt. Ltd. February, 2025 TNPR19910765
Best Price Guarantee
Price from $5,795
Length 242 Pages
Publisher Transparency Market Research Pvt. Ltd.
Published Date February, 2025
SKU TNPR19910765

Canine Atopic Dermatitis Market – Scope of Report

TMR’s report on the global canine atopic dermatitis market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global canine atopic dermatitis market for the period 2019–2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global canine atopic dermatitis market from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the canine atopic dermatitis market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global canine atopic dermatitis market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global canine atopic dermatitis market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global canine atopic dermatitis market.

The report delves into the competitive landscape of the global canine atopic dermatitis market. Key players operating in the global canine atopic dermatitis market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global canine atopic dermatitis market profiled in this report.

Key Questions Answered in Global canine atopic dermatitis Market Report

  • What is the sales/revenue generated by canine atopic dermatitis across all regions during the forecast period?
  • What are the opportunities in the global canine atopic dermatitis market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2035?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?
Canine Atopic Dermatitis Market – Research Objectives and Research Approach

The comprehensive report on the global canine atopic dermatitis market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global canine atopic dermatitis market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global canine atopic dermatitis market.


1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Canine Atopic Dermatitis Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Canine Atopic Dermatitis Market Analysis and Forecasts, 2020-2035
4.4.1. Market Revenue Projections (US$ Bn)
5. Key Insights
5.1. Healthcare Expenditure Data across Key Countries
5.2. Brand and Pricing Analysis
5.3. Recent Advancements in Canine Atopic Dermatitis
5.4. PORTER’s Five Forces Analysis
5.5. Regulatory Landscape across Key Regions / Countries
5.6. Go-to-Market Strategy for New Market Entrants across Key Regions / Countries
5.7. Supply Chain Analysis
5.8. Value Chain Analysis
5.9. PESTLE Analysis
5.10. Key Potential Customers
6. Global Canine Atopic Dermatitis Market Analysis and Forecasts, By Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Product Type, 2020-2035
6.3.1. Glucocorticoids
6.3.2. Immunosuppressants
6.3.3. Monoclonal Antibodies
6.3.4. Calcineurin Inhibitors
6.3.5. Janus kinase (JAK) Inhibitor
6.3.6. Others
6.4. Market Attractiveness By Product Type
7. Global Canine Atopic Dermatitis Market Analysis and Forecasts, By Route of Administration
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast By Route of Administration, 2020-2035
7.3.1. Topical
7.3.2. Oral
7.3.3. Injectable
7.4. Market Attractiveness By Route of Administration
8. Global Canine Atopic Dermatitis Market Analysis and Forecasts, By Distribution Channel
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast By Distribution Channel, 2020-2035
8.3.1. Veterinary Hospitals and Clinics
8.3.2. Veterinary Pharmacies & Drug Stores
8.3.3. E-commerce
8.3.4. Others
8.4. Market Attractiveness By Distribution Channel
9. Global Canine Atopic Dermatitis Market Analysis and Forecasts, By Region
9.1. Key Findings
9.2. Market Value Forecast By Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness By Country/Region
10. North America Canine Atopic Dermatitis Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast By Product Type, 2020-2035
10.2.1. Glucocorticoids
10.2.2. Immunosuppressants
10.2.3. Monoclonal Antibodies
10.2.4. Calcineurin Inhibitors
10.2.5. Janus kinase (JAK) Inhibitor
10.2.6. Others
10.3. Market Value Forecast By Route of Administration, 2020-2035
10.3.1. Topical
10.3.2. Oral
10.3.3. Injectable
10.4. Market Value Forecast By Distribution Channel, 2020-2035
10.4.1. Veterinary Hospitals and Clinics
10.4.2. Veterinary Pharmacies & Drug Stores
10.4.3. E-commerce
10.4.4. Others
10.5. Market Value Forecast By Country, 2020-2035
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product Type
10.6.2. By Route of Administration
10.6.3. By Distribution Channel
10.6.4. By Country
11. Europe Canine Atopic Dermatitis Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast By Product Type, 2020-2035
11.2.1. Glucocorticoids
11.2.2. Immunosuppressants
11.2.3. Monoclonal Antibodies
11.2.4. Calcineurin Inhibitors
11.2.5. Janus kinase (JAK) Inhibitor
11.2.6. Others
11.3. Market Value Forecast By Route of Administration, 2020-2035
11.3.1. Topical
11.3.2. Oral
11.3.3. Injectable
11.4. Market Value Forecast By Distribution Channel, 2020-2035
11.4.1. Veterinary Hospitals and Clinics
11.4.2. Veterinary Pharmacies & Drug Stores
11.4.3. E-commerce
11.4.4. Others
11.5. Market Value Forecast By Country, 2020-2035
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product Type
11.6.2. By Route of Administration
11.6.3. By Distribution Channel
11.6.4. By Country
12. Asia Pacific Canine Atopic Dermatitis Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast By Product Type, 2020-2035
12.2.1. Glucocorticoids
12.2.2. Immunosuppressants
12.2.3. Monoclonal Antibodies
12.2.4. Calcineurin Inhibitors
12.2.5. Janus kinase (JAK) Inhibitor
12.2.6. Others
12.3. Market Value Forecast By Route of Administration, 2020-2035
12.3.1. Topical
12.3.2. Oral
12.3.3. Injectable
12.4. Market Value Forecast By Distribution Channel, 2020-2035
12.4.1. Veterinary Hospitals and Clinics
12.4.2. Veterinary Pharmacies & Drug Stores
12.4.3. E-commerce
12.4.4. Others
12.5. Market Value Forecast By Country, 2020-2035
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product Type
12.6.2. By Route of Administration
12.6.3. By Distribution Channel
12.6.4. By Country
13. Latin America Canine Atopic Dermatitis Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast By Product Type, 2020-2035
13.2.1. Glucocorticoids
13.2.2. Immunosuppressants
13.2.3. Monoclonal Antibodies
13.2.4. Calcineurin Inhibitors
13.2.5. Janus kinase (JAK) Inhibitor
13.2.6. Others
13.3. Market Value Forecast By Route of Administration, 2020-2035
13.3.1. Topical
13.3.2. Oral
13.3.3. Injectable
13.4. Market Value Forecast By Distribution Channel, 2020-2035
13.4.1. Veterinary Hospitals and Clinics
13.4.2. Veterinary Pharmacies & Drug Stores
13.4.3. E-commerce
13.4.4. Others
13.5. Market Value Forecast By Country, 2020-2035
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Argentina
13.5.4. Chile
13.5.5. Peru
13.5.6. Colombia
13.5.7. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product Type
13.6.2. By Route of Administration
13.6.3. By Distribution Channel
13.6.4. By Country
14. Middle East & Africa Canine Atopic Dermatitis Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast By Product Type, 2020-2035
14.2.1. Glucocorticoids
14.2.2. Immunosuppressants
14.2.3. Monoclonal Antibodies
14.2.4. Calcineurin Inhibitors
14.2.5. Janus kinase (JAK) Inhibitor
14.2.6. Others
14.3. Market Value Forecast By Route of Administration, 2020-2035
14.3.1. Topical
14.3.2. Oral
14.3.3. Injectable
14.4. Market Value Forecast By Distribution Channel, 2020-2035
14.4.1. Veterinary Hospitals and Clinics
14.4.2. Veterinary Pharmacies & Drug Stores
14.4.3. E-commerce
14.4.4. Others
14.5. Market Value Forecast By Country, 2020-2035
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product Type
14.6.2. By Route of Administration
14.6.3. By Distribution Channel
14.6.4. By Country
15. Competitive Landscape
15.1. Market Player - Competition Matrix (By Tier and Size of companies)
15.2. Market Share Analysis, by Company (2024)
15.3. Company Profiles
15.3.1. Zoetis
15.3.1.1. Company Overview
15.3.1.2. Financial Overview
15.3.1.3. Product Portfolio
15.3.1.4. Business Strategies
15.3.1.5. Recent Developments
15.3.2. Merck & Co., Inc.
15.3.2.1. Company Overview
15.3.2.2. Financial Overview
15.3.2.3. Product Portfolio
15.3.2.4. Business Strategies
15.3.2.5. Recent Developments
15.3.3. Elanco or its affiliates.
15.3.3.1. Company Overview
15.3.3.2. Financial Overview
15.3.3.3. Product Portfolio
15.3.3.4. Business Strategies
15.3.3.5. Recent Developments
15.3.4. Boehringer Ingelheim International GmbH
15.3.4.1. Company Overview
15.3.4.2. Financial Overview
15.3.4.3. Product Portfolio
15.3.4.4. Business Strategies
15.3.4.5. Recent Developments
15.3.5. Virbac Corporation
15.3.5.1. Company Overview
15.3.5.2. Financial Overview
15.3.5.3. Product Portfolio
15.3.5.4. Business Strategies
15.3.5.5. Recent Developments
15.3.6. Vetoquinol
15.3.6.1. Company Overview
15.3.6.2. Financial Overview
15.3.6.3. Product Portfolio
15.3.6.4. Business Strategies
15.3.6.5. Recent Developments
15.3.7. TORAY INDUSTRIES, INC.
15.3.7.1. Company Overview
15.3.7.2. Financial Overview
15.3.7.3. Product Portfolio
15.3.7.4. Business Strategies
15.3.7.5. Recent Developments
15.3.8. Biocelix
15.3.8.1. Company Overview
15.3.8.2. Financial Overview
15.3.8.3. Product Portfolio
15.3.8.4. Business Strategies
15.3.8.5. Recent Developments
15.3.9. Dechra Pharmaceuticals PLC
15.3.9.1. Company Overview
15.3.9.2. Financial Overview
15.3.9.3. Product Portfolio
15.3.9.4. Business Strategies
15.3.9.5. Recent Developments
15.3.10. Bioiberica S.A.U
15.3.10.1. Company Overview
15.3.10.2. Financial Overview
15.3.10.3. Product Portfolio
15.3.10.4. Business Strategies
15.3.10.5. Recent Developments
15.3.11. Ceva
15.3.11.1. Company Overview
15.3.11.2. Financial Overview
15.3.11.3. Product Portfolio
15.3.11.4. Business Strategies
15.3.11.5. Recent Developments
15.3.12. Bimeda Corporate
15.3.12.1. Company Overview
15.3.12.2. Financial Overview
15.3.12.3. Product Portfolio
15.3.12.4. Business Strategies
15.3.12.5. Recent Developments
15.3.13. Other prominent players
15.3.13.1. Company Overview
15.3.13.2. Financial Overview
15.3.13.3. Product Portfolio
15.3.13.4. Business Strategies
15.3.13.5. Recent Developments

$5,795
$8,795
$11,795

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings